QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 159 filers reported holding QIAGEN NV in Q2 2014. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,091,000 | +9.4% | 395,843 | +7.2% | 0.05% | +8.0% |
| Q3 2016 | $10,136,000 | +30.6% | 369,402 | +3.7% | 0.05% | +25.0% |
| Q2 2016 | $7,763,000 | +26.7% | 356,297 | +29.9% | 0.04% | +29.0% |
| Q1 2016 | $6,128,000 | +11.0% | 274,292 | +37.4% | 0.03% | +6.9% |
| Q4 2015 | $5,523,000 | +31.6% | 199,694 | +22.7% | 0.03% | +26.1% |
| Q3 2015 | $4,198,000 | +54.6% | 162,774 | +48.4% | 0.02% | +76.9% |
| Q2 2015 | $2,715,000 | -20.1% | 109,670 | -18.7% | 0.01% | -18.8% |
| Q1 2015 | $3,400,000 | -72.4% | 134,904 | -74.3% | 0.02% | -70.9% |
| Q4 2014 | $12,299,000 | +40.5% | 524,637 | +36.5% | 0.06% | +31.0% |
| Q3 2014 | $8,754,000 | +854.6% | 384,357 | +917.1% | 0.04% | +950.0% |
| Q2 2014 | $917,000 | +64.9% | 37,791 | +42.8% | 0.00% | +33.3% |
| Q1 2014 | $556,000 | -57.9% | 26,473 | -53.3% | 0.00% | -57.1% |
| Q4 2013 | $1,322,000 | – | 56,668 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BLUE JAY CAPITAL MANAGEMENT, LLC | 438,572 | $12,289,000 | 7.42% |
| Tikvah Management LLC | 369,425 | $10,749,000 | 5.28% |
| Hardman Johnston Global Advisors LLC | 3,700,819 | $103,697,000 | 5.06% |
| HealthCor Management, L.P. | 2,850,000 | $79,857,000 | 4.51% |
| Opus Point Partners Management, LLC | 111,683 | $3,129,000 | 2.49% |
| Exane Asset Management | 286,810 | $7,509,412,000 | 2.47% |
| GO ETF SOLUTIONS LLP | 68,960 | $1,932,000 | 1.46% |
| Douglas Lane & Associates, LLC | 1,816,416 | $50,896,000 | 1.30% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,471,580 | $41,233,000 | 1.21% |
| Ghost Tree Capital, LLC | 135,000 | $3,783,000 | 0.91% |